FDA Vaccines and Related Biological Products Advisory Committee(VRBPAC) Meeting  Dec. 10, 2020
CDC Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer-BioNTech COVID-19 Vaccine
VRBPAC Dec. 10, 2020
briefing document (FDA)
briefing document (Pfizer)
BNT162b2 Vaccine Candidate Against COVID-19 (Pfizer)
NEJM article
COVID-19 Vaccine Post-authorization Safety and Effectiveness Monitoring
![[Image: image.png]](https://i.ibb.co/sHsrBth/image.png)
![[Image: image.png]](https://i.ibb.co/BPxX2Zh/image.png)
![[Image: image.png]](https://i.ibb.co/5LwQzWy/image.png)
CDC Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer-BioNTech COVID-19 Vaccine
VRBPAC Dec. 10, 2020
briefing document (FDA)
briefing document (Pfizer)
BNT162b2 Vaccine Candidate Against COVID-19 (Pfizer)
NEJM article
COVID-19 Vaccine Post-authorization Safety and Effectiveness Monitoring
![[Image: image.png]](https://i.ibb.co/sHsrBth/image.png)
![[Image: image.png]](https://i.ibb.co/BPxX2Zh/image.png)
![[Image: image.png]](https://i.ibb.co/5LwQzWy/image.png)
![[Image: image.png]](https://i.ibb.co/8zzNWNJ/image.png)